Merck
MRK
#64
Rank
NZ$418.60 B
Marketcap
NZ$167.59
Share price
-2.06%
Change (1 day)
-2.85%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$13.10

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$13.13. In 2024 the company made an earnings per share (EPS) of NZ$11.69 an increase over its 2023 EPS that were of NZ$0.27.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$13.1012.06%
2024NZ$11.694308.46%
2023NZ$0.27-97.32%
2022NZ$9.9110.92%
2021NZ$8.9484.68%
2020NZ$4.84-27.2%
2019NZ$6.6563.44%
2018NZ$4.07151.11%
2017NZ$1.62-54.58%
2016NZ$3.5630.21%
2015NZ$2.74-61.99%
2014NZ$7.20180.51%
2013NZ$2.57-31.82%
2012NZ$3.776.62%
2011NZ$3.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.98-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.06 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$35.49 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.14-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.41-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.22-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.09-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.73-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
NZ$13.94 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$22.54 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA